CD28 Regulation of Alternative Splicing Changes in Human T cells
CD28 Regulation of Alternative Splicing Changes in Human T cells
批准号:
10252785
负责人:
Davia Blake
金额:
$3.4万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-01-01 至 2023-12-31
关键词:
Alternative SplicingAntibodiesAntigen-Presenting CellsApoptoticCASP9 geneCD28 geneCD3 AntigensCD4 Positive T LymphocytesCell DeathCell SurvivalCell physiologyCellsComputer softwareCultured CellsDataEventExhibitsExonsFutureGene ExpressionGenesGeneticGoalsHarvestHigh-Throughput Nucleotide SequencingHumanImmune systemInfectionKnowledgeMessenger RNAMonoclonal Antibody HuM291PTPRC genePeptidesPhenotypePhysiologicalPoly AProcessProductionProtein IsoformsProtein Tyrosine PhosphataseProteinsRNARNA ProcessingRNA SplicingRNA-Binding ProteinsRegulationReverse Transcriptase Polymerase Chain ReactionRoleSamplingSignal PathwaySignal TransductionSpliced GenesStimulusSuggestionT-Cell ActivationT-Cell ReceptorT-LymphocyteTestingTranscriptWorkcytokineexon skippingnovelpathogenreceptorresponsetooltranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Alternative splicing consists of exons that are selectively included or excluded from the mature mRNA
transcript. In fact, most protein encoding genes, approximately 95%, contain an alternative exon. Previous
studies recognized that a subset of alternative spliced genes, 10-15%, undergo changes in isoform abundance
upon activation of primary human CD4+ T cells. A well-characterized example of signal-induced alternative
splicing changes includes a tyrosine phosphatase receptor, CD45, where the increased abundance of the
shorter RNA isoform is correlated with an increased activation threshold from future stimuli. Regulatory
mechanisms including the role of signaling pathways and RNA binding proteins influencing splicing changes
have been characterized by our lab and others. However, the field lacks general knowledge of the role and
mechanism of differential T cell stimuli to regulate global splicing changes.
Previous studies investigated signal-induced alternative splicing changes with T cells activated in the
presence of anti-CD3 and anti-CD28 stimuli. CD3 is a component of the T cell receptor (TCR), which is
responsible for recognizing peptides presented by antigen presenting cells in the context of an infection. CD28
is a costimulatory receptor that enhances many signaling events downstream of the TCR. We ask if global
alternative splicing changes are differentially influenced by the presence of CD28 costimulation in primary
human CD4+ T cells. Therefore, I acquired primary CD4+ CD45RO- T cells from three human donors and
cultured the cells in the following conditions: media alone, anti-CD28 antibody, anti-CD3 antibody, or anti-
CD3/CD28 together. I harvested RNA for high-throughput sequencing analysis and discovered a subset of
alternative splicing events that are influenced by the presence CD28 costimulation compared to splicing events
regulated by CD3 stimulation alone. One of these splicing events includes a multi-exon skipping event within
Casapse-9 transcript that has not been characterized in CD4+ T cells. We hypothesize that the multi-exon
skipping event is regulating T cell survival upon stimulation. In our proposal, we plan to elucidate mechanisms
of splicing changes regulated by CD28 costimulation and the functional consequences of such events, such as
the multi-exon skipping event in Caspase-9 and impact on T cell survival. Overall, this work will be the stepping
stone into knowing how global alternative splicing events are regulated and the impact on cellular functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CD28 Regulation of Alternative Splicing Changes in Human T cells
-
批准号:10543406
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2021
-
负责人:Davia Blake
-
依托单位:
海外基金